CompletedNot Applicable

Perioperative Hypogonadism in Men Undergoing Radical Cystoprostatectomy for Bladder Cancer

United States25 participantsStarted 2017-03-31

Plain-language summary

The purpose of this study is to examine the relationship between testosterone level changes around the time of radical cystectomy.

Who can participate

Age range18 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of bladder cancer * Scheduled to undergo radical cystectomy Exclusion Criteria: * Evidence of advanced metastatic disease, * Undergoing cystectomy for non-bladder primary malignancy or bladder cancer type other than urothelial cell * History of breast or prostate cancer * Polycythemia, cardiovascular thromboembolism, untreated obstructive sleep apnea, uncontrolled heart failure, or acute coronary event in the past six months

What they're measuring

Number of Hypogonadism in Participants Based on Serum Testosterone 90 Days Post Radical

Timeframe: 90 days post-RC surgery

Trial details

NCT IDNCT03063125

SponsorUniversity of Kansas Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2018-04-20

Results submitted2020-09-08

View on ClinicalTrials.gov More Bladder Cancer trials